Such antiproliferative effect of exendin-4 on prostate cancer was not via androgen receptor, but through the inhibition of extracellular signal–regulated kinase-mitogen-activated protein kinase (ERK-MAPK) phosphorylation via GLP-1R [26]. Here, GLP1R is linked to prostate cancer.